Literature DB >> 26746214

Targeting BRAF mutants in clear-cell sarcomas of soft tissue: beyond sarcoma or melanoma classification.

Arnaud Uguen1,2,3,4, Pascale Marcorelles5,6,7, Marc De Braekeleer8,6,9.   

Abstract

Entities:  

Keywords:  Atypical melanocytic tumors; BRAF; Clear cell sarcoma; EWSR1; Melanoma

Mesh：

Substances：

Year:  2016        PMID： 26746214     DOI： 10.1007/s10637-015-0319-2

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  3 in total

1.  Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.

Authors:  Thomas Wiesner; Jie He; Roman Yelensky; Rosaura Esteve-Puig; Thomas Botton; Iwei Yeh; Doron Lipson; Geoff Otto; Kristina Brennan; Rajmohan Murali; Maria Garrido; Vincent A Miller; Jeffrey S Ross; Michael F Berger; Alyssa Sparatta; Gabriele Palmedo; Lorenzo Cerroni; Klaus J Busam; Heinz Kutzner; Maureen T Cronin; Philip J Stephens; Boris C Bastian
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

2.  BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.

Authors:  Svetlana A Protsenko; Anna I Semionova; Yuri I Komarov; Svetlana N Aleksakhina; Alexandr O Ivantsov; Aglaya G Iyevleva; Evgeny N Imyanitov
Journal:  Invest New Drugs       Date:  2015-08-20       Impact factor: 3.850

3.  Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases.

Authors:  O Hocar; A Le Cesne; S Berissi; P Terrier; S Bonvalot; D Vanel; A Auperin; C Le Pechoux; B Bui; J M Coindre; C Robert
Journal:  Dermatol Res Pract       Date:  2012-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.